A shelf full of antihistamines

With its newly licensed oral histamine H1 receptor antagonist, Inspire Pharmaceuticals Inc. thinks it can cover the delivery preferences of patients in the crowded allergy space.

Inspire (ISPH, Durham, N.C.) last week obtained U.S. and Canadian rights to develop and commercialize oral bilastine to treat or prevent rhinitis from

Read the full 490 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE